The use of nanotechnology in biomedicine involves the engineering of nanomaterials to act as therapeutic carriers, targeting agents and diagnostic imaging devices. The application of nanotechnology in cancer aims to transform early detection, targeted therapeutics and cancer prevention and control. To assist in expediting and validating the use of nanomaterials in biomedicine, the National Cancer Institute (NCI) Center for Biomedical Informatics and Information Technology, in collaboration with the NCI Alliance for Nanotechnology in Cancer (Alliance), has developed a data sharing portal called caNanoLab. caNanoLab provides access to experimental and literature curated data from the NCI Nanotechnology Characterization Laboratory, the Alliance and the greater cancer nanotechnology community.
caNanoLab data repository development and curation was sponsored by SAIC-Frederick subcontract 29XS232. Data curation was sponsored by contract 12XS412 (Essential Software Inc.). The Nanomaterial Registry, NBI, InterNano, NIL and ChemBench teams are acknowledged for contributing information for table 1, a comparison of nanotechnology resources.
1. Hinkal G W, Farrell D, Hook S S, Panaro N J, Ptak K and Grodzinski P 2011 Cancer therapy through nanomedicine IEEE Nanotechnol. Mag. 5 6–12 2. Thomas D G et al 2013 ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based format BMC Biotechnol. 13 2 3. Baker N A, Klemm J D, Harper S L, Gaheen S, Heiskanen M, Rocca-Serra P and Sansone S A 2013 Standardizing data Nature Nanotechnol. 8 73–4 CrossRef
Researchers should cite this work as follows: